Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
>=0.1-<1
General Information
Version
3.3
Revision date
2020-10-10
Product name
Olmesartan / Amlodipine Besylate Formulation
1.2.1 Relevant identified uses
Pharmaceutical
supplier name
Merck & Co., Inc
Emergency telephone
1-908-423-6000
Icons in SDS
Company Information
company name
Merck & Co., Inc
e-mail address of the competent person responsible for the Safety Data Sheet
EHSDATASTEWARD@merck.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H319, H351, H360D
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Eye irritation : Category 2A Carcinogenicity (Inhalation) : Category 2 Reproductive toxicity
Signal word
Danger
Hazard statements
H319 Causes serious eye irritation. H351 Suspected of causing cancer if inhaled. H360D May damage the unborn child.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P264 Wash skin thoroughly after handling. P280 Wear protective gloves, protective clothing, eye protection and face protection.
Response
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or concerned: Get medical attention. P337 + P313 If eye irritation persists: Get medical attention.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents and container to an approved waste disposal plant.
Other hazards
Contact with dust can cause mechanical irritation or drying of the skin. May form explosive dust-air mixture during processing, handling or other means
